Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women

作者: B G Haffty

DOI: 10.1136/JMG.2005.034744

关键词:

摘要: Purpose: To evaluate the frequency and distribution of BRCA1 BRCA2 mutations in a cohort young women with breast cancer to compare as function race. Methods: After IRB approved informed consent, 170 white 30 African American known diagnosed at age (45 years or less) underwent complete sequencing genes. Each represented approximately 40% same ethnic background aged 45 younger database. Results: Of 200 patients tested, 131 (65%) had wild type mutations, 34 (17%) deleterious 35 (18%) variants uncertain significance. There were no significant differences between cohorts regarding percentage (17% v 17%). However, most (4/5, 80%), while (20/29, 69%). In addition, 46% significance, compared only 12% cohort. Conclusions: Young have similar women, but significantly higher Review these revealed that majority unlikely be associated disease risk likely polymorphisms. The implications for genetic testing counselling are discussed.

参考文章(35)
Foluso O. Ademuyiwa, Olufunmilayo I. Olopade, Racial differences in genetic factors associated with breast cancer. Cancer and Metastasis Reviews. ,vol. 22, pp. 47- 53 ,(2003) , 10.1023/A:1022259901319
S Neuhausen, O I Olopade, S Cummings, Q Gao, M Luce, RECURRENT GERM-LINE BRCA1 MUTATIONS IN EXTENDED AFRICAN AMERICAN FAMILIES WITH EARLY-ONSET BREAST CANCER American Journal of Human Genetics. ,vol. 60, pp. 1233- 1236 ,(1997)
A. de la Rochefordière, F. Campana, J. Fenton, J.R. Vilcoq, A. Fourquet, B. Asselain, S.M. Scholl, P. Pouillart, J.-C. Durand, H. Magdelenat, Age as prognostic factor in premenopausal breast carcinoma. The Lancet. ,vol. 341, pp. 1039- 1043 ,(1993) , 10.1016/0140-6736(93)92407-K
Frank A. Vicini, Larry L. Kestin, Neal S. Goldstein, Peter Y. Chen, Jane Pettinga, Robert C. Frazier, Alvaro A. Martinez, Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. Journal of Clinical Oncology. ,vol. 18, pp. 296- 306 ,(2000) , 10.1200/JCO.2000.18.2.296
M Robson, T Gilewski, B Haas, D Levin, P Borgen, P Rajan, Y Hirschaut, P Pressman, P P Rosen, M L Lesser, L Norton, K Offit, BRCA-associated breast cancer in young women. Journal of Clinical Oncology. ,vol. 16, pp. 1642- 1649 ,(1998) , 10.1200/JCO.1998.16.5.1642
Timothy R. Rebbeck, Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers Journal of Clinical Oncology. ,vol. 18, ,(2000)
Ford, D, Easton, DF, Bishop, DT, Narod, SA, Goldgar, DE and the Breast Cancer Linkage Consortium, None, Risks of cancer in BRCA1-mutation carriers The Lancet. ,vol. 343, pp. 692- 695 ,(1994) , 10.1016/S0140-6736(94)91578-4
Abram Recht, James L. Connolly, Stuart J. Schnitt, Barbara Silver, Mary Ann Rose, Susan Love, Jay R. Harris, The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. International Journal of Radiation Oncology Biology Physics. ,vol. 14, pp. 3- 10 ,(1988) , 10.1016/0360-3016(88)90043-0
Yan Ansquer, Chantal Gautier, Alain Fourquet, Bernard Asselain, Dominique Stoppa-Lyonnet, Survival in early-onset BRCA1 breast-cancer patients The Lancet. ,vol. 352, pp. 541- ,(1998) , 10.1016/S0140-6736(05)79248-5